These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reply: To PMID 24332219. van Til NP; Cortes P; Danos O; Cassani B; Poliani PL; Villa A; Wagemaker G J Allergy Clin Immunol; 2014 Jul; 134(1):243-4. PubMed ID: 25117804 [No Abstract] [Full Text] [Related]
3. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome. van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219 [TBL] [Abstract][Full Text] [Related]
4. Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer. Pike-Overzet K; Rodijk M; Ng YY; Baert MR; Lagresle-Peyrou C; Schambach A; Zhang F; Hoeben RC; Hacein-Bey-Abina S; Lankester AC; Bredius RG; Driessen GJ; Thrasher AJ; Baum C; Cavazzana-Calvo M; van Dongen JJ; Staal FJ Leukemia; 2011 Sep; 25(9):1471-83. PubMed ID: 21617701 [TBL] [Abstract][Full Text] [Related]
5. Promising Results with Ex Vivo Lentiviral HSPC Gene Therapy in ADA-SCID. Am J Med Genet A; 2021 Aug; 185(8):2291-2292. PubMed ID: 34240545 [No Abstract] [Full Text] [Related]
6. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency. Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239 [TBL] [Abstract][Full Text] [Related]
7. Three faces of recombination activating gene 1 (RAG1) mutations. Patiroglu T; Akar HH; Van Der Burg M Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875 [TBL] [Abstract][Full Text] [Related]
8. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells. Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421 [TBL] [Abstract][Full Text] [Related]
9. Novel Compound Heterozygous Mutations in RAG1 in a Patient with Cutaneous Lymphoproliferative Disease. Xu CC; Chen MZ; Xiong JS; Gan L; Zhang Y; Chen H; Sun JF Acta Derm Venereol; 2019 Jan; 99(1):105-106. PubMed ID: 30226529 [No Abstract] [Full Text] [Related]
10. IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID. Safaei S; Pourpak Z; Moin M; Houshmand M Iran J Allergy Asthma Immunol; 2011 Jun; 10(2):129-32. PubMed ID: 21625022 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy of primary T cell immunodeficiencies. Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799 [TBL] [Abstract][Full Text] [Related]
12. [Gene therapy of severe combined immunodeficiencies]. Cavazzana-Calvo M; Hacein-Bey S; de Saint-Basile G; Le Deist F; Fischer A Transfus Clin Biol; 2000 Jun; 7(3):259-60. PubMed ID: 10919216 [No Abstract] [Full Text] [Related]
13. Immunodeficiencies: injecting some safety into SCID gene therapy? Candotti F; Roifman C; Puck JM Gene Ther; 2006 May; 13(9):741-3. PubMed ID: 18360945 [No Abstract] [Full Text] [Related]
14. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome. Dalal I; Tasher D; Somech R; Etzioni A; Garti BZ; Lev D; Cohen S; Somekh E; Leshinsky-Silver E Clin Immunol; 2011 Sep; 140(3):284-90. PubMed ID: 21624848 [TBL] [Abstract][Full Text] [Related]
15. Severe combined immunodeficiency in Frisian Water Dogs caused by a RAG1 mutation. Verfuurden B; Wempe F; Reinink P; van Kooten PJ; Martens E; Gerritsen R; Vos JH; Rutten VP; Leegwater PA Genes Immun; 2011 Jun; 12(4):310-3. PubMed ID: 21293384 [TBL] [Abstract][Full Text] [Related]
16. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt. Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295 [TBL] [Abstract][Full Text] [Related]
17. Ten years of gene therapy for primary immune deficiencies. Aiuti A; Roncarolo MG Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254 [TBL] [Abstract][Full Text] [Related]
18. Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations. Szaflarska A; Rutkowska-Zapała M; Kotula M; Gruca A; Grabowska A; Lenart M; Surman M; Trzyna E; Mordel A; Pituch-Noworolska A; Siedlar M Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):177-183. PubMed ID: 28083621 [TBL] [Abstract][Full Text] [Related]